大家都在搜
手机验证
Sealed in dry,2-8°C
详见产品说明
Ginsenoside Rb3
999
仕诺达生物
68406-26-8
20mg(多规格可选)
中文名 | 人参皂甙 Rb3 |
英文名 | ginsenoside rb3 |
别名 | 红茶浸膏粉 人参皂苷Rb3 人参皂荚RB2 人参皂甙 Rb3 人参皂甙 RB3 人参皂苷 Rb3 人参皂苷RB3对照品, 人参皂苷RB3(标准品) 人参皂苷RB3(人参皂荚RB2 人参皂苷 RB3, 来源于人参 GINSENOSIDE RB3 人参皂甙 RB3 |
英文别名 | Gypenoside IV xylopyranosyl- ginsenoside rb3 Ginsenoside Rb3 GINSENOSIDE Rb3(SH) hydroxydammar-24-en-20-yl6-O-β-D- β-D-Glucopyranoside, (3β,12β)-3-[(2-O-β-D- glucopyranosyl)oxy)-12-hydroxydammar-24-en-20-yl6-o-beta-d-xylopyranosyl- [3β-[[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyl]oxy]-12β-hydroxy-5α-dammar-24-en-20-yl]6-O-(β-D-xylopyranosyl)-β-D-glucopyranoside alpha-D-Glucopyranoside, (3-beta,12-beta)-3-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-20-yl 6-O-beta-D-xylopyranosyl- (1R,4E)-1-{(8xi,9xi,12α,13xi,14β)-3-[(2-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-12-hydroxy-4,4,10,14-tetramethylgonan-17-yl}-1,5-dimethylhept-4-en-1-yl 6-O-β-D-xylopyranosyl-β-D-allopyranoside |
CAS | 68406-26-8 |
化学式 | C53H90O22 |
分子量 | 1079.27 |
InChI | InChI=1/C53H90O22/c1-8-23(2)10-9-15-53(7,75-48-44(67)40(63)38(61)31(72-48)22-69-46-42(65)35(58)28(57)21-68-46)25-13-16-52(6)24-11-12-32-50(3,4)33(14-17-51(32,5)26(24)18-27(56)34(25)52)73-49-45(41(64)37(60)30(20-55)71-49)74-47-43(66)39(62)36(59)29(19-54)70-47/h10,24-49,54-67H,8-9,11-22H2,1-7H3/b23-10+/t24?,25?,26?,27-,28+,29+,30+,31+,32?,33?,34?,35-,36+,37+,38+,39-,40+,41-,42+,43+,44+,45+,46-,47-,48-,49-,51+,52+,53+/m0/s1 |
密度 | 1.42±0.1 g/cm3(Predicted) |
熔点 | 193~195℃ |
沸点 | 1117.1±65.0 °C(Predicted) |
比旋光度 | (c, 1 in MeOH)+19.4 |
闪点 | 634.2°C |
蒸汽压 | 0mmHg at 25°C |
溶解度 | DMSO (微溶) 、甲醇 (微溶) 、吡啶 (微溶) |
折射率 | 1.621 |
酸度系数 | 12.85±0.70(Predicted) |
存储条件 | Sealed in dry,2-8°C |
稳定性 | 吸湿性 |
敏感性 | Easily absorbing moisture |
外观 | 整洁 |
颜色 | White |
物化性质 | 白色结晶粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于人参,绞股蓝。 |
MDL号 | MFCD10566396 |
体外研究 | Ginsenoside Rb3 (0.1-10 μM) is tested for inhibition of tumor necrosis factor-α (TNF)-induced nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) luciferase reporter activity using a human kidney 293T cell-based assay. Ginsenoside Rb3 shows the significant activity with an IC 50 of 8.2 μM. Ginsenoside Rb3 also inhibits the induction of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) messenger Ribonucleic acid (mRNA) in a dose-dependent manner after HepG2 cells have been treated with TNF-α (10 ng/mL). Ginsenoside Rb3 (0.1-10 μM) significantly increases cell viability and inhibits lactate dehydrogenase (LDH) release in a dose-dependent manner. PC12 cell viability as determined by MTT reduction is also markedly decreased after the cell is exposed to oxygen and glucose deprivation (OGD)/OGD-Rep. But, when the cells are pretreated with Ginsenoside Rb3 (0.1, 1, and 10 μM), OGD/OGD-Rep induced cell toxicity is significantly attenuated, which is concentration-dependently attenuated by Ginsenoside Rb3 treatment. The viabilities are raised to 52.8%±5.6%, 64.6%±5.7%, and 76.4%±8.8%, respectively, compared with the control group. |
体内研究 | Ginsenosides Rb3 is a major compound isolated from Gynostemma pentaphyllum that holistically improves gut microenvironment and induces anti-polyposis in Apc Min/+ mice. Six-weeks-old mice are subjected to Rb3 treatment, before the appearance of the intestinal polyps. All the mice are monitored for food intake, water consumption, and weight changes. Throughout the experiment, no Rb3/Rd-associated weight loss in mice is observed. In addition, none of the treated mice show variations in food and water consumption. Whereas, the number and size of the polyps are effectively reduced by Rb3 treatments. |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
微信图片_20200713091731.jpg 附 (下载 0 次)